Pemphigus
Symptoms, Doctors, Treatments, Advances & More

Pemphigus Overview

Save information for later
Sign Up

Learn About Pemphigus

What is the definition of Pemphigus?
Pemphigus is a group of rare autoimmune diseases that cause blistering of the skin and mucous membranes (mouth, nose, throat, eyes, and genitals). This condition can occur at any age, but often strikes people in middle or older age. Studies have shown that some populations may be at greater risk for certain types of Pemphigus. For instance, people of Jewish descent and those from India, Southeast Europe, and the Middle East are at greater risk for Pemphigus vulargis, while Pemphigus foliaceus is more common in North America, Turkey, and South America.
What are the alternative names for Pemphigus?
  • Pemphigus
Who are the top Pemphigus Local Doctors?
Elite in Pemphigus
Elite in Pemphigus
Referral may be required

UCI Health Dermatology Center

850 Health Sciences Road, Floor 2, 
Irvine, CA 
949-824-0606
Languages Spoken:
English, Russian
See accepted insurances
Offers Telehealth

Dr. Sergei Grando is a board-certified UCI Health dermatologist with more than 30 years experience treating skin disorders including eczema and other autoimmune blistering diseases.He received his medical degree at Kyiv Medical University in Kyiv, Ukraine. He completed residencies in dermatology Kyiv Medical University and at the UC Davis School of Medicine in Sacramento, Calif. He also received a doctorate in pharmacology and biochemistry at the National Medical Academy of Postgraduate Education in Kyiv, and a doctorate of science in immunology and cell biology from the Central Institute of Dermatology and Venereology in Moscow, Russia.Grando's research interests include pemphigus, keratinocyte adhesion and migration, and the cholinergic effects of tobacco products in non-neuronal tissue. He has published more than 225 papers, monographs and book chapters, and has been awarded numerous research grants from the National Institutes of Health and other funding agencies. Dr. Grando is rated as an Elite provider by MediFind in the treatment of Pemphigus. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Pemphigus Vulgaris, Pemphigus, Pemphigus Foliaceus, and Bullous Pemphigoid. Dr. Grando is board certified in American Board Of Dermatology - Dermatology.

Elite in Pemphigus
Dr. Ron J. Feldman
Dermatology
Elite in Pemphigus
Dr. Ron J. Feldman
Dermatology
Referral required

Emory Clinic At 1525 Clifton Road

1525 Clifton Road Northeast, Fl3, 
Atlanta, GA 
404-778-3333
Experience:
21+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ron Feldman is a Dermatologist practicing medicine in Atlanta, Georgia. He has been practicing medicine for over 21 years. Dr. Feldman is rated as an Elite provider by MediFind in the treatment of Pemphigus. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Pemphigus Foliaceus, Pemphigus, Bullous Pemphigoid, and Pemphigus Vulgaris. Dr. Feldman is board certified in American Board Of Dermatology, 2010.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Pemphigus
Dr. Aimee Payne
Dermatology
Elite in Pemphigus
Dr. Aimee Payne
Dermatology
Referral may be required

CUIMC/Herbert Irving Pavilion

161 Fort Washington Ave, 
New York, NY 
914-768-8691
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Aimee Payne is a Dermatologist practicing medicine in New York, New York. Dr. Payne is rated as an Elite provider by MediFind in the treatment of Pemphigus. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Pemphigus, Pemphigus Vulgaris, Pemphigus Foliaceus, and Bullous Pemphigoid.

View All Doctors
What are the latest Pemphigus Clinical Trials?
Evaluation of the Effectiveness of Clobetasol Propionate 0.05% and Photobiomodulation in the Management of Oral Lesions in Patients With Pemphigus Vulgaris. (Three-arm Randomized Controlled Clinical Study)
Evaluation of the Effectiveness of Clobetasol Propionate 0.05% and Photobiomodulation in the Management of Oral Lesions in Patients With Pemphigus Vulgaris. (Three-arm Randomized Controlled Clinical Study)
Enrollment Status: Recruiting
Publish Date: June 11, 2026
Intervention Type: Device, Drug
Study Phase: Not Applicable

Summary: Pemphigus vulgaris (PV) is a chronic, potentially life-threatening autoimmune mucocutaneous disorder that significantly impairs patients' quality of life. While systemic corticosteroids and immunosuppressants remain the standard of care, many patients suffer from persistent, painful oral lesions that exhibit delayed healing or poor response to conventional systemic protocols. This clinical trial i...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris
Who is this study for: Adult patients with Mucosal-Dominant Pemphigus Vulgaris
Enrollment Status: Recruiting
Publish Date: May 29, 2026
Intervention Type: Biological
Study Drug: Autologous Desmoglein 3 CAR-T Cells
Study Phase: Phase 1/Phase 2

Summary: A phase 1/2, open-label, safety and dosing study of autologous CART cells (desmoglein 3 chimeric autoantibody receptor T cells \[DSG3-CAART\] or CD19-specific Chimeric Antigen Receptor T cells \[CABA-201\]) in subjects with active, pemphigus vulgaris

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center